Concepedia

Michael Imboden

MI

10

Publications

506

Citations

10

H-Index

2001

Active since

Affiliations

University of Wisconsin–Madison(Current)

University of Arizona

ioGenetics (United States)

Scripps Research Institute

Michael Imboden is an author at University of Wisconsin–Madison specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

2001–2020

10

Publications

10

Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells

Joel G. Turner, Alexander L. Rakhmilevich, Lyudmila G. Burdelya et al. · The Journal of Immunology · 2001 · 103 citations · Full text

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich et al. · Clinical Cancer Research · 2004 · 93 citations

Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa

Sujun Li, Shyamtanu Datta, Emily Brabbit et al. · Gene Therapy · 2020 · 61 citations · Full text

Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.

Alexander L. Rakhmilevich, Michael Imboden, Zhengling Hao et al. · PubMed · 2001 · 51 citations

, , +16

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy

Zane C. Neal, Michael Imboden, Alexander L. Rakhmilevich et al. · Cancer Immunology Immunotherapy · 2003 · 48 citations · Full text

, , +10

Rows per page

1–5 of 10